Back to search
FDAFDA · Food and drugs·Recall number D-1103-2018

Valsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-360-30

Published August 29, 2018 · Recall initiated: August 14, 2018

Summary

FDA records drug Class III recall D-1103-2018, published August 29, 2018 and initiated August 14, 2018. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 10,577 bottles; Lot: Lot #: VR117014A, VR117015A, Exp. 08/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Jubilant Cadista Pharmaceuticals, Inc.
Distributor
Product was distributed throughout the United States to wholesalers and retailers.
Lot
Lot #: VR117014A, VR117015A, Exp. 08/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Valsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-360-30 recalled?

Yes. FDA published recall D-1103-2018 on August 29, 2018. Reported hazard: Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter